Margaretha Jurstrand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Margaretha Jurstrand has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Hans Fredlund
Department of Clinical Microbiology1, Outpatient Sexually Transmitted Disease Clinic, Department of Dermatovenereology3, and Clinical Research Centre4, Örebro University Hospital, SE-70185 Örebro, Sweden 2Mycoplasma Laboratory, Department of Respiratory Infections, Meningitis and Sexually Transmitted Infections, Statens Serum Institut, DK-2300 Copenhagen, Denmark
2 shared publicationsLars Falk
Department of Clinical Microbiology1, Outpatient Sexually Transmitted Disease Clinic, Department of Dermatovenereology3, and Clinical Research Centre4, Örebro University Hospital, SE-70185 Örebro, Sweden 2Mycoplasma Laboratory, Department of Respiratory Infections, Meningitis and Sexually Transmitted Infections, Statens Serum Institut, DK-2300 Copenhagen, Denmark
2 shared publicationsAnders Bäckman
Department of Clinical Microbiology and Immunology1 and Outpatient Sexually Transmitted Disease Clinic, Department of Dermatovenereology,2Örebro Medical Centre Hospital, SE-70185 Örebro, Department of Clinical Microbiology, Malmö University Hospital, SE-20502 Malmö,3 and Division of Virology, Department of Microbiology, Pathology and Immunology, Karolinska Institutet, Huddinge University Hospital, SE-14186 Huddinge/Stockholm,4 Sweden
1 shared publicationJan Albert
Department of Clinical Microbiology and Immunology1 and Outpatient Sexually Transmitted Disease Clinic, Department of Dermatovenereology,2Örebro Medical Centre Hospital, SE-70185 Örebro, Department of Clinical Microbiology, Malmö University Hospital, SE-20502 Malmö,3 and Division of Virology, Department of Microbiology, Pathology and Immunology, Karolinska Institutet, Huddinge University Hospital, SE-14186 Huddinge/Stockholm,4 Sweden
1 shared publication- Jørgen Skov Jensen
Research Unit for Reproductive Microbiology, Statens Serum Institut , Copenhagen
1 shared publication Kenneth Persson
Department of Clinical Microbiology and Immunology1 and Outpatient Sexually Transmitted Disease Clinic, Department of Dermatovenereology,2Örebro Medical Centre Hospital, SE-70185 Örebro, Department of Clinical Microbiology, Malmö University Hospital, SE-20502 Malmö,3 and Division of Virology, Department of Microbiology, Pathology and Immunology, Karolinska Institutet, Huddinge University Hospital, SE-14186 Huddinge/Stockholm,4 Sweden
1 shared publication
Latest Publications
- 1 January 2005
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 54 (1) , 23-29
Detection of Mycoplasma genitalium in urogenital specimens by real-time PCR and by conventional PCR assay
A real-time LightCycler PCR (LC-PCR) with hybridization probes for detection of Mycoplasma genitalium in endocervical and first void urine specimens was developed and compared to a conventional PCR. The primers for both assays were identical and designed to amplify a 427 bp fragment of the 16S rRNA gene of M. genitalium. The LC-PCR assay had a detection limit of < 5 bacterial genomes per reaction when dilutions of genomic DNA from a type strain of M. genitalium were tested. First void urine from 398 men and first void urine and endocervical specimens from 301 women attending an STD clinic were analysed by LC-PCR and by the conventional PCR. Using the conventional PCR as reference, the LC-PCR had a specificity of 99.7 % and a sensitivity of 72.2 % for the detection of M. genitalium in first void urine samples from men. There was no significant difference in the performance of the LC-PCR assay compared to the conventional PCR when endocervical swabs were considered (58 and 65 %, respectively) or with a set of endocervical swab/urine specimens for which the LC-PCR assay detected 73 % of the infections (specificity = 98.6 % and sensitivity = 68.2 %) while the conventional PCR detected 85 % of the infections. With female urine specimens there was a significant difference between the two assays (38 and 73 %, respectively; P = 0.01 McNemar's test). This illustrates the need to analyse both endocervical and urine specimens, because M. genitalium DNA was detected in only one of the two specimens in a great number of the M. genitalium-infected women. The lower sensitivity of the LC-PCR assay was probably caused by a combination of inhibition and limitations regarding the amount of template DNA. The LC-PCR assay was easy to perform and the simultaneous amplification and detection eliminated the need for further handling of PCR products. With improvement in sample preparation methods and increased volumes of the template DNA, the LC-PCR assay could be a useful routine diagnostic method.
- 1 January 2005
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 54 (1) , 23-29
Detection of Mycoplasma genitalium in urogenital specimens by real-time PCR and by conventional PCR assay
A real-time LightCycler PCR (LC-PCR) with hybridization probes for detection of Mycoplasma genitalium in endocervical and first void urine specimens was developed and compared to a conventional PCR. The primers for both assays were identical and designed to amplify a 427 bp fragment of the 16S rRNA gene of M. genitalium. The LC-PCR assay had a detection limit of < 5 bacterial genomes per reaction when dilutions of genomic DNA from a type strain of M. genitalium were tested. First void urine from 398 men and first void urine and endocervical specimens from 301 women attending an STD clinic were analysed by LC-PCR and by the conventional PCR. Using the conventional PCR as reference, the LC-PCR had a specificity of 99.7 % and a sensitivity of 72.2 % for the detection of M. genitalium in first void urine samples from men. There was no significant difference in the performance of the LC-PCR assay compared to the conventional PCR when endocervical swabs were considered (58 and 65 %, respectively) or with a set of endocervical swab/urine specimens for which the LC-PCR assay detected 73 % of the infections (specificity = 98.6 % and sensitivity = 68.2 %) while the conventional PCR detected 85 % of the infections. With female urine specimens there was a significant difference between the two assays (38 and 73 %, respectively; P = 0.01 McNemar's test). This illustrates the need to analyse both endocervical and urine specimens, because M. genitalium DNA was detected in only one of the two specimens in a great number of the M. genitalium-infected women. The lower sensitivity of the LC-PCR assay was probably caused by a combination of inhibition and limitations regarding the amount of template DNA. The LC-PCR assay was easy to perform and the simultaneous amplification and detection eliminated the need for further handling of PCR products. With improvement in sample preparation methods and increased volumes of the template DNA, the LC-PCR assay could be a useful routine diagnostic method.
- Open Access
- 1 November 2001
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 39 (11) , 3915-3919
Characterization of Chlamydia trachomatis omp1 Genotypes among Sexually Transmitted Disease Patients in Sweden
A method for detection and genotyping of genital Chlamydia trachomatis infections based on omp1 gene amplification and sequencing was developed. DNA was extracted from urogenital or urine samples using a Chelex-based method, and an approximately 1,100-bp-long fragment from the omp1 gene was directly amplified and sequenced. Genotyping was performed by BLAST similarity search, and phylogenetic tree analysis was used to illustrate the evolutionary relationships between clinical isolates and reference strains. The method was used to determine the genotypes of C. trachomatis in 237 positive urogenital and/or urine specimens collected at a Swedish sexually transmitted disease clinic during 1 year. The most common genotypes corresponded to serotypes E (47%) and F (17%). The omp1 gene was highly conserved for genotype E (106 of 112 samples without any mutation) and F (41 of 42 samples without any mutation) strains but appear slightly less conserved for genotypes G ( n = 6) and H ( n = 6), where the sequences displayed one to four nucleotide substitutions relative to the reference sequence. Genotyping of samples collected at the follow-up visit indicated that two patients had become reinfected, while three other patients suffered treatment failure or reinfection. One woman appeared to have a mixed infection with two different C. trachomatis strains. This omp1 genotyping method had a high reproducibility and could be used for epidemiological characterization of sexually transmitted Chlamydia infections.
- 1 November 2001
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 39 (11) , 3915-3919
Open AccessCharacterization of Chlamydia trachomatis omp1 Genotypes among Sexually Transmitted Disease Patients in Sweden
A method for detection and genotyping of genital Chlamydia trachomatis infections based on omp1 gene amplification and sequencing was developed. DNA was extracted from urogenital or urine samples using a Chelex-based method, and an approximately 1,100-bp-long fragment from the omp1 gene was directly amplified and sequenced. Genotyping was performed by BLAST similarity search, and phylogenetic tree analysis was used to illustrate the evolutionary relationships between clinical isolates and reference strains. The method was used to determine the genotypes of C. trachomatis in 237 positive urogenital and/or urine specimens collected at a Swedish sexually transmitted disease clinic during 1 year. The most common genotypes corresponded to serotypes E (47%) and F (17%). The omp1 gene was highly conserved for genotype E (106 of 112 samples without any mutation) and F (41 of 42 samples without any mutation) strains but appear slightly less conserved for genotypes G ( n = 6) and H ( n = 6), where the sequences displayed one to four nucleotide substitutions relative to the reference sequence. Genotyping of samples collected at the follow-up visit indicated that two patients had become reinfected, while three other patients suffered treatment failure or reinfection. One woman appeared to have a mixed infection with two different C. trachomatis strains. This omp1 genotyping method had a high reproducibility and could be used for epidemiological characterization of sexually transmitted Chlamydia infections.